Q2 2025 Earnings Call Transcript August 7, 2025 Operator: Good day, and thank you for standing by. Welcome to the Arcutis ...

Corvus Pharmaceuticals reported a net loss per share of $(0.10) for Q2 2025, a smaller loss than the analyst estimate of $(0.13). Research and development expenses rose sharply to $7.9 million, ...

Integrating waste foundry sand with SCMs like metakaolin and silica fume significantly boosts concrete strength and ...

Key Points Revenue (GAAP) rose 30% to $98.0 million in the quarter, topping GAAP revenue estimates by $5.85 million. Earnings per share (GAAP) of $(0.20) missed GAAP EPS estimates due to higher R&D ...

Thailand and Cambodia signed an extended 13-point peace agreement on Thursday (August 7) to end their five-day border war, while the stench ...

Pipeline Regulatory Progress -- Two risk-adjusted product launches (AMP-002 and AMP-015) are included in the flat full-year ...

Live Nation promoted nearly 55,000 events in 2024, eclipsing its prepandemic high of 40,000 in 2019. To win tours to promote, the firm offers artists very generous profit splits—often more than ...

Detailed price information for Tantalus Systems Holding Inc (GRID-T) from The Globe and Mail including charting and trades.

Delivered an oral presentation at ASCO 2025 Annual Meeting, demonstrating extended median progression-free survival (mPFS) in ...

Tunisia’s recent trajectory has been marked by a serious regression in terms of civil liberties, particularly since 2023. The ...

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today ...

In January 2024, Knight announced that it had entered into an agreement with Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal") for the exclusive rights to seek regulatory approval and ...